SEC Form 4 · accession 0001181431-15-003461
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael David Staffieri
Officer — COO, Kidney Care
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 7:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2015 | A | 45,000 | $41.505 | A | 45,394 | D | |
| Common Stock | Feb 24, 2015 | F | 25,288 | $73.86 | D | 20,106 | D | |
| Common StockF1 | Feb 24, 2015 | S | 19,712 | $73.5831 | D | 394 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF2 | $41.505 | Feb 24, 2015 | M | 45,000 | D | Mar 29, 2014 | Mar 29, 2016 | Common Stock | 45,000 | 15,000 | D |
Explanation of responses
- F1Represents the weighted average sale price of $73.5831. The range of prices for the sale of these shares was $73.465 - $73.66, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F2Stock Appreciation Rights, granted on 3/29/2011, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 50% on the third and fourth anniversaries of the grant date.